Stanford, UCLA Study Finds "Excess Risk Of Serious Adverse Events" From Pfizer, Moderna COVID Jabs

Tyler Durden's Photo
by Tyler Durden
Thursday, Jun 23, 2022 - 01:05 AM

A preprint study that has not yet undergone peer review has found that there were 'serious adverse events of special interest' when performing a secondary analysis of vaccine injuries reported in the Phase III randomized clinical trials of both Pfizer and Moderna's Covid-19 jabs.

A team of researchers from across the globe - including Stanford University, UCLA, Louisiana State University, and the University of Maryland School of Pharmacy applied a new method of analysis to the Phase III results.